AZD9291, known as osimertinib, is a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in the treatment of EGFR-mutated non-small cell lung cancer. This… Read more






![Chemical structure of N-(5-((4-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1825287-91-9-N-5-4-56-dihydro-4H-pyrrolo321-ijquinolin-1-ylpyrimidin-2-ylamino-2-2-dimethylaminoethylmethylamino-4-methoxyphenylacrylamide.png&w=3840&q=75)
![Chemical structure of N-(5-((4-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-(methyl(2-(methyl(methyl-d3)amino)ethyl)amino)phenyl)acrylamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2211116-92-4-N-5-4-56-Dihydro-4H-pyrrolo321-ijquinolin-1-ylpyrimidin-2-ylamino-4-methoxy-2-methyl2-methylmethyl-d3aminoethylaminophenylacrylamide.png&w=3840&q=75)

![Chemical structure of N-Des[2-(Dimethylamino)Ethyl] Osimertinib](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-Des2-DimethylaminoEthyl-Osimertinib.png&w=3840&q=75)
![Chemical structure of N-Nitroso N-Des[2-(Dimethylamino)Ethyl] Osimertinib](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-Nitroso-N-Des2-DimethylaminoEthyl-Osimertinib.png&w=3840&q=75)








![Chemical structure of N4-(4-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)pyrimidin-2-yl)-5-methoxy-N1-methyl-N1-(2-(methyl(methyl-d3)amino)ethyl)benzene-1,2,4-triamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2211116-74-2-N4-4-56-dihydro-4H-pyrrolo321-ijquinolin-1-ylpyrimidin-2-yl-5-methoxy-N1-methyl-N1-2-methylmethyl-d3aminoethylbenzene-124-triamine.png&w=3840&q=75)
![Chemical structure of N4-(4-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)pyrimidin-2-yl)-N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methylbenzene-1,2,4-triamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1825290-88-7-N4-4-56-dihydro-4H-pyrrolo321-ijquinolin-1-ylpyrimidin-2-yl-N1-2-dimethylaminoethyl-5-methoxy-N1-methylbenzene-124-triamine.png&w=3840&q=75)





























AZD9291, known as osimertinib, is a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in the treatment of EGFR-mutated non-small cell lung cancer. This category includes the active pharmaceutical ingredient, its salt forms, and a comprehensive range of related compounds, such as synthetic impurities, degradation products, and stable isotope labelled standards. These high-quality reference standards are essential for pharmaceutical laboratories during analytical testing, impurity profiling, and method validation to ensure regulatory compliance and product quality. Stable isotope labelled compounds, such as deuterated and 13C-labelled variants, are particularly vital for precise quantification in high-resolution mass spectrometry and bioanalytical studies. By utilizing these characterized materials, researchers and quality control specialists can accurately identify, monitor, and quantify trace components, ultimately supporting the development of robust, stability-indicating analytical methods and maintaining stringent pharmaceutical safety standards.